medicine semaglutide Demand Rising for 'Bootlegged' Weight-Loss Drug FDA Warns on Certain Forms

has received research support from investigator-initiated sponsored proposals from Novo Nordisk, Zealand Pharma and Boehringer-Ingelheim

In MCL (medial collateral ligament) transection studies, BPC-157 restored biomechanical properties to near-normal levels

Most people tolerate the GLP-1 plus GIP medication well, but mild side effects can occur as your body adjusts

In: Aronson J.K., editor

Current recommendations from the American Society of Anesthesiologists (ASA) suggest withholding GLP-1 agonists one week prior to the procedure for those on weekly dosing and withholding GLP-1 agonists on the day of the procedure (American Society of Anesthesiologists 2024)